2024年欧洲结核病监测与监控数据

2024 data2026 Tuberculosis surveillanceand monitoring in Europe2026 2024 data This report has been published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WorldHealth Organization (WHO) Regional Office for Europe. ECDC developed the overview of the EU/EEA countries and vali-dated the EU/EEA figures, and the WHO Regional Office for Europe developed the overview of the European Region as awhole and validated the figures of the non-member countries of the European Union (EU)/European Economic Area (EEA). KeywordsTUBERCULOSIS – EPIDEMIOLOGYTB – EPIDEMIOLOGYTB SURVEILLANCE All reasonable precautions have been taken by ECDC and theWorld Health Organization to verify the information containedin this publication. However, the published material is distributedwithout warranty of any kind, either expressed or implied. Theresponsibility for the interpretation and use of the material lieswith the reader. Under no circumstances shall ECDC or the WorldHealth Organization be liable for damages arising from its use. © European Centre for Disease Prevention and Control and WorldHealth Organization 2026 Some rights reserved. This work is available under the CreativeCommons Attribution- 4.0 International licence (CC BY-4.0;Creative Commons Attribution 4.0 International license). In any use of this work, there should be no suggestion that WHOor ECDC endorse any specific organisations, products or services.The use of the ECDC or WHO logo is not permitted. If you translatethis work, you should add the following disclaimer along withthe suggested citation: ’This translation was not provided bythe European Centre for Disease Prevention and Control (ECDC)or by the World Health Organization (WHO). ECDC and WHO arenot responsible for the content or accuracy of this translation.The original English edition shall be the binding and authenticedition’. The WHO Regional Office for Europe is responsible for the accu-racy of the translation of the Russian summary. Cataloguing-in-Publication (CIP) data. CIP data are available athttp://apps.who.int/iris. Third-party materials. If you wish to reuse material from thiswork that is attributed to a third party, such as tables, figuresor images, or maps, it is your responsibility to determine whetherpermission is needed for that reuse and to obtain permissionfrom the copyright holder. The risk of claims resulting frominfringement of any third-party-owned component in the workrests solely with the user. Maps for which WHO is identified ascopyright holder require prior authorisation of WHO beforereproduction or translation of substantial parts. Authorisationcan be required through the permission form at the followinglink: https://www.who.int/about/who-we-are/publishing-poli-cies/permissions Suggested citation for full report: European Centre for DiseasePrevention and Control/WHO Regional Office for Europe.Tuberculosis surveillance and monitoring in Europe 2026 – 2024data. Stockholm: ECDC/WHO Regional Office for Europe; 2026. Tables and figures should be referenced: European Centre forDisease Prevention and Control/WHO Regional Office for Europe.Tuberculosis surveillance and monitoring in Europe 2026 – 2024data. Stockholm: ECDC/WHO Regional Office for Europe; 2026. Cover picture:© Science Photo Library This publication follows ECDC institutional style guidelineswhich reflect the European Union Inter-Institutional Style Guidewith regard to names and designation of countries, territories,areas and cities, or their authorities. The names and designa-tions of countries, territories, areas and cities used in thispublication should not be understood as an endorsement byWHO of the terminology used. The designations employed and the presentation of the materialin this publication do not imply the expression of any opinionwhatsoever on the part of the World Health Organization andECDC concerning the legal status of any country, territory, area,city or their authorities, or concerning the delimitation of itsfrontiers or boundaries. Dotted lines on maps represent approxi-mate border lines for which there may not yet be fullagreement. The mention of specific companies or certain manufacturers’products does not imply that they are endorsed or recommendedby the World Health Organization and ECDC in preference toothers of a similar nature that are not mentioned. Errors andomissions excepted, the names of proprietary products aredistinguished by initial capital letters. Contents Acknowledgements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .vAbbreviations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .